Quarterly report pursuant to Section 13 or 15(d)

Collaboration and Research Arrangements (Tables)

v3.22.1
Collaboration and Research Arrangements (Tables)
3 Months Ended
Mar. 31, 2022
Collaborative Arrangement Disclosure [Abstract]  
Schedule of Change in Accounts Receivable, Contract Assets and Liabilities

The following table presents the changes in accounts receivable, contract assets and liabilities for the three months ended March 31, 2022 (in thousands):

 

 

 

Balance at

December

31, 2021

 

 

Additions

 

 

Deductions

 

 

Balance at March 31, 2022

 

Accounts receivable and contract assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Billed receivables from collaboration partners

 

$

 

 

$

2,857

 

 

$

(2,857

)

 

$

 

Unbilled receivables from collaboration partners

 

 

2,979

 

 

 

3,181

 

 

 

(2,978

)

 

 

3,182

 

Total accounts receivable and contract assets

 

$

2,979

 

 

$

6,038

 

 

$

(5,835

)

 

$

3,182

 

Contract liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue - Incyte

 

$

1,268

 

 

$

 

 

$

(421

)

 

$

847

 

Deferred revenue - GBT

 

 

8,913

 

 

 

 

 

 

(1,987

)

 

 

6,926

 

Total contract liabilities

 

$

10,181

 

 

$

 

 

$

(2,408

)

 

$

7,773